Hypokalemia: a clinical update.
Article Details
- CitationCopy to clipboard
Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A
Hypokalemia: a clinical update.
Endocr Connect. 2018 Apr;7(4):R135-R146. doi: 10.1530/EC-18-0109. Epub 2018 Mar 14.
- PubMed ID
- 29540487 [ View in PubMed]
- Abstract
Hypokalemia is a common electrolyte disturbance, especially in hospitalized patients. It can have various causes, including endocrine ones. Sometimes, hypokalemia requires urgent medical attention. The aim of this review is to present updated information regarding: (1) the definition and prevalence of hypokalemia, (2) the physiology of potassium homeostasis, (3) the various causes leading to hypokalemia, (4) the diagnostic steps for the assessment of hypokalemia and (5) the appropriate treatment of hypokalemia depending on the cause. Practical algorithms for the optimal diagnostic, treatment and follow-up strategy are presented, while an individualized approach is emphasized.
DrugBank Data that Cites this Article
- Drugs
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Potassium Sodium/potassium-transporting ATPase subunit alpha-1 Protein Humans UnknownRegulatorDetails - Drug Transporters
Drug Transporter Kind Organism Pharmacological Action Actions Potassium Sodium/potassium-transporting ATPase subunit alpha-1 Protein Humans UnknownSubstrateDetails - Drug Interactions
Drugs Interaction Integrate drug-drug
interactions in your softwareOlodaterolCaffeine Caffeine may increase the hyperkalemic activities of Olodaterol. OlodaterolTheophylline Theophylline may increase the hyperkalemic activities of Olodaterol. OlodaterolDyphylline Dyphylline may increase the hyperkalemic activities of Olodaterol. OlodaterolPentoxifylline Pentoxifylline may increase the hyperkalemic activities of Olodaterol. OlodaterolMercaptopurine Mercaptopurine may increase the hyperkalemic activities of Olodaterol.